CGAS promotes cellular senescence and the senescence-associated secretory phenotype in cells, results reproduced by independent labs. One mouse study reports that CGAS extends lifespan and reduces frailty, whereas a killifish knockout study shows no clear lifespan effect. Mouse inflammation results point both ways.
78 findings in 41 papers from 2017 to 2026, 9 of them since April 2026
The findings reach people, from one lab or study; independent labs found the same change in cells and mice. 119 independent labs in 24 countries; 1 trial.
“In human lung adenocarcinoma patients, low expression of cGAS is correlated with poor survival.”
Cells and mice: replicated by independent labs. Worms or flies and humans: a single group.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
Includes the processes named after it and trials of drugs aimed at it.
119 independent labs in 24 countries
7 findings against
1 trial
Funders: National Natural Science Foundation of China and others
16 of 239 findings with company ties
1 of 1 trial sponsored by developers of drugs aimed at it
Human trial2
Humans22
Animals197
Cells64
In silico1
Interventions
2
Flavin adenine dinucleotide
↓downin mouse cells1
1 study
Flavin adenine dinucleotide inhibits CGAS in mouse cells.
“It bound directly to cytosolic nucleic acid sensors cyclic GMP-AMP synthase (cGAS) and retinoic acid-inducible gene I (RIG-I), occupying catalytic pockets to suppress their activity”
CGAS increases cellular senescence in human cells (D-galactose-treated HAECs; shown by inhibitor and siRNA knockdown) (partial reversal of senescence).
“D-GAL induced a decrease in eNOS expression and cell senescence, which could be partly reversed by cGAS inhibitor, STING inhibitor, siRNA-cGAS and siRNA-STING treatment.”
CellsD-galactose-treated HAECs; shown by inhibitor and siRNA knockdownendothelial cells
CGAS increases cellular senescence in cells (shown by genetic and pharmacological manipulation; in response to dysfunctional telomeres).
“genetic and pharmacological manipulation of cGAS not only attenuated immune signaling, but also prevented premature cellular senescence in response to dysfunctional telomeres”
Cellsshown by genetic and pharmacological manipulation; in response to dysfunctional telomeres
CGAS is required for senescence-associated secretory phenotype (SASP) in mouse cells (SASP induced by spontaneous immortalization, radiation or etoposide).
“cGAS deletion also abrogated SASP induced by spontaneous immortalization or DNA damaging agents, including radiation and etoposide.”
CellsSASP induced by spontaneous immortalization, radiation or etoposide
“cyclic GMP-AMP synthase (cGAS) recognizing cytosolic chromatin fragments and then activating the stimulator of interferon genes (STING) cytosolic DNA-sensing pathway”
CGAS is associated with disrupted micronuclei in cells (compared with intact micronuclei) (approximately 80% of disrupted micronuclei versus few intact micronuclei).
“cGAS was found to localize to approximately 80% of the disrupted MN but few for intact MN”
cGAS knockout shows mixed effects: one mouse study reports less inflammation, transposable element activity and frailty but shorter lifespan. One killifish study reports reduced senescence-associated beta-galactosidase without lifespan change, while cGAS-deficient killifish cells show increased DNA damage responses.
Experiments in mice with osteoarthritis found that inhibiting or removing the channel also reduced bone hardening and senescence, a state in which cartilage cells stop…Experiments in mice with osteoarthritis found that inhibiting or removing the channel also reduced bone hardening and senescence, a state in which cartilage cells stop dividing.
Mice engineered to increase glucose breakdown in blood vessel–lining cells showed poorer blood-flow recovery and lower capillary density after hindlimb blood supply was…Mice engineered to increase glucose breakdown in blood vessel–lining cells showed poorer blood-flow recovery and lower capillary density after hindlimb blood supply was restricted.
An experiment comparing 8- and 56-week-old female mice found the worst damage after interrupted liver blood flow in older mice missing a DNA-sensing enzyme.An experiment comparing 8- and 56-week-old female mice found the worst damage after interrupted liver blood flow in older mice missing a DNA-sensing enzyme.
A selective protein inhibitor reduced disease severity in two experimental models of colitis, a form of intestinal inflammation.A selective protein inhibitor reduced disease severity in two experimental models of colitis, a form of intestinal inflammation.
In a dialysis mouse model, the protein SIRT3 also suppressed immune cell senescence, a state in which cells stop dividing.In a dialysis mouse model, the protein SIRT3 also suppressed immune cell senescence, a state in which cells stop dividing.
Accepted, not yet published: mouse studyInterventions
Who was studiedMice
What changedSIRT3 reduced scarring of the abdominal lining in mice
The catchThe abstract does not quantify the reduction in scarring